![Alliance for Regenerative Medicine Logo](https://alliancerm.org/wp-content/uploads/2018/05/arm_logo_white_text.png)
Arcellx
Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases. Arcellx’s vision is to bring ARC-SparX platform cell therapies to millions of patients who can self-administer prescribed SparX proteins under the care of academic and community practices. |